World's Best Scientists 2026 revealed!
Philippe De Deurwaerdère

Philippe De Deurwaerdère

D-Index & Metrics

Neuroscience

D-Index
44
Citations
7257
World Ranking
7190
National Ranking
321

Overview

Philippe De Deurwaerdère is affiliated with the University of Bordeaux in France and conducts research primarily within the fields of neuroscience, medicine, and biochemistry, genetics, and molecular biology. Their work is notably concentrated in subfields such as cellular and molecular neuroscience, molecular biology, neurology, cognitive neuroscience, and clinical psychology.

The research topics covered by Philippe De Deurwaerdère include:

  • Neurotransmitter Receptor Influence on Behavior
  • Neuroscience and Neuropharmacology Research
  • Receptor Mechanisms and Signaling
  • Parkinson's Disease Mechanisms and Treatments
  • Psychedelics and Drug Studies
  • Nicotinic Acetylcholine Receptors Study
  • Neurological disorders and treatments

Their recent papers reflect this range of topics and areas of study. Selected works include:

  • "Serotonin in Animal Cognition and Behavior" (2020), published in the International Journal of Molecular Sciences
  • "The Noradrenergic System in Parkinson's Disease" (2020), published in Frontiers in Pharmacology
  • "Serotonin in Health and Disease" (2020), published in the International Journal of Molecular Sciences
  • "Constitutive activity of 5-HT receptors: Factual analysis" (2020), published in Neuropharmacology
  • "Serotonin modulation of hippocampal functions: From anatomy to neurotherapeutics" (2021), published in Progress in Brain Research

Philippe De Deurwaerdère collaborates frequently with a group of co-authors, indicating ongoing cooperative research efforts. The most frequent collaborators include:

  • Abdeslam Chagraoui
  • Giuseppe Di Giovanni
  • Rahul Bharatiya
  • Jasmine Jade Butler
  • Chloé Aman

Their work appears repeatedly in several scientific journals, reflecting consistent contributions to specific publication venues. These venues are:

  • International Journal of Molecular Sciences
  • Progress in Brain Research
  • Frontiers in Pharmacology
  • European Journal of Pharmacology
  • Neuropharmacology

Philippe De Deurwaerdère's research focus encompasses multiple aspects of neurotransmitter receptor function and signaling mechanisms, with particular attention to their role in behavior and neurological disorders such as Parkinson's disease. The emphasis on molecular and cellular neuroscience is evident through their broad and interdisciplinary approach, linking neuropharmacology, molecular biology, and clinical perspectives across numerous publications.

Best Publications

  • Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease.

    Matthieu F. Bastide;Wassilios G. Meissner;Barbara Picconi;Stefania Fasano

  • Constitutive Activity of the Serotonin2C Receptor Inhibits In Vivo Dopamine Release in the Rat Striatum and Nucleus Accumbens

    Philippe De Deurwaerdère;Sylvia Navailles;Kelly A. Berg;William P. Clarke

  • Serotonin in Animal Cognition and Behavior.

    Julien Bacqué-Cazenave;Rahul Bharatiya;Grégory Barrière;Jean-Paul Delbecque

  • Anxiety-like behavior in crayfish is controlled by serotonin

    Pascal Fossat;Pascal Fossat;Julien Bacqué-Cazenave;Julien Bacqué-Cazenave;Philippe De Deurwaerdère;Philippe De Deurwaerdère;Jean-Paul Delbecque;Jean-Paul Delbecque

  • 5-HT2A and 5-HT2C/2B receptor subtypes modulate dopamine release induced in vivo by amphetamine and morphine in both the rat nucleus accumbens and striatum.

    Grégory Porras;Vincenzo Di Matteo;Claudia Fracasso;Guillaume Lucas

  • Noradrenaline and Parkinson's Disease

    Claire Delaville;Philippe De Deurwaerdère;Abdelhamid Benazzouz

  • Serotonergic neurons mediate ectopic release of dopamine induced by l-DOPA in a rat model of Parkinson's disease

    Sylvia Navailles;Bernard Bioulac;Christian Gross;Philippe De Deurwaerdère

  • Role of Serotonin2A and Serotonin2B/2C Receptor Subtypes in the Control of Accumbal and Striatal Dopamine Release Elicited In Vivo by Dorsal Raphe Nucleus Electrical Stimulation

    Philippe De Deurwaerdère;Umberto Spampinato

  • Serotonergic modulation of the activity of mesencephalic dopaminergic systems: Therapeutic implications

    Philippe De Deurwaerdère;Giuseppe Di Giovanni

  • Opposite Change of In Vivo Dopamine Release in the Rat Nucleus Accumbens and Striatum That Follows Electrical Stimulation of Dorsal Raphe Nucleus: Role of 5-HT3 Receptors

    Philippe De Deurwaerdère;Luis Stinus;Umberto Spampinato

  • Expanding the repertoire of L-DOPA’s actions: A comprehensive review of its functional neurochemistry

    Philippe De Deurwaerdère;Giuseppe Di Giovanni;Giuseppe Di Giovanni;Mark J. Millan

  • High-frequency stimulation of the subthalamic nucleus and L-3,4-dihydroxyphenylalanine inhibit in vivo serotonin release in the prefrontal cortex and hippocampus in a rat model of Parkinson's disease.

    Sylvia Navailles;Abdelhamid Benazzouz;Bernard Bioulac;Christian Gross

  • Presynaptic control of serotonin on striatal dopamine function

    Sylvia Navailles;Philippe De Deurwaerdère

  • The Noradrenergic System in Parkinson's Disease.

    Elena Paredes-Rodriguez;Sergio Vegas-Suarez;Teresa Morera-Herreras;Philippe De Deurwaerdere

  • 8-OH-DPAT, a 5-HT1A agonist and ritanserin, a 5-HT2A/C antagonist, reverse haloperidol-induced catalepsy in rats independently of striatal dopamine release

    Guillaume Lucas;Norbert Bonhomme;Philippe De Deurwaerdère;Michel Le Moal

  • New therapeutic opportunities for 5-HT2C receptor ligands in neuropsychiatric disorders.

    Giuseppe Di Giovanni;Giuseppe Di Giovanni;Philippe De Deurwaerdère

  • Emerging dysfunctions consequent to combined monoaminergic depletions in Parkinsonism.

    Claire Delaville;Jonathan Chetrit;Khaled Abdallah;Stéphanie Morin

  • In vivo evidence that 5-HT2C receptor antagonist but not agonist modulates cocaine-induced dopamine outflow in the rat nucleus accumbens and striatum.

    Sylvia Navailles;Philippe De Deurwaerdère;Grégory Porras;Umberto Spampinato

  • Chronic L-DOPA therapy alters central serotonergic function and L-DOPA-induced dopamine release in a region-dependent manner in a rat model of Parkinson's disease

    Sylvia Navailles;Bernard Bioulac;Bernard Bioulac;Christian Gross;Christian Gross;Philippe De Deurwaerdère;Philippe De Deurwaerdère

  • Serotonin Enhances Striatal Dopamine Outflow In Vivo Through Dopamine Uptake Sites

    Philippe De Deurwaerdère;Norbert Bonhomme;Guillaume Lucas;Michel Le Moal

  • The effect of serotonergic agents on haloperidol-induced striatal dopamine release in vivo: opposite role of 5-HT2A and 5-HT2C receptor subtypes and significance of the haloperidol dose used

    Guillaume Lucas;Philippe De Deurwaerdère;Silvio Caccia;Umberto Spampinato

Frequent Co-Authors

Giuseppe Di Giovanni
Giuseppe Di Giovanni Magna Graecia University
Umberto Spampinato
Umberto Spampinato University of Bordeaux
Abdelhamid Benazzouz
Abdelhamid Benazzouz University of Bordeaux
Marie-Françoise Chesselet
Marie-Françoise Chesselet University of California, Los Angeles
Christian E. Gross
Christian E. Gross University of Bordeaux
Ilse Smolders
Ilse Smolders Vrije Universiteit Brussel
Pierre-Olivier Fernagut
Pierre-Olivier Fernagut University of Poitiers
Bernard Bioulac
Bernard Bioulac University of Bordeaux
Manolo Carta
Manolo Carta University of Cagliari
Ennio Esposito
Ennio Esposito Mario Negri Institute for Pharmacological Research

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Philippe De Deurwaerdère

Trending Scientists